Clostridium spores for tumor-specific drug delivery

Anti-Cancer Drugs

Volumn 13, Issue 2, 2002, Pages 115-125

  Nuyts, Sandra ^a   Van Mellaert, L ^a   Theys, J ^a   Landuyt, W ^a   Lambin, P ^a   Anne J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Anti cancer therapy; Clostridium; Gene transfer; Hypoxia; Radio induction; Review; Tumor

Indexed keywords

5 (1 AZIRIDINYL) 2,4 DINITROBENZAMIDE; ANTINEOPLASTIC AGENT; BACTERIAL TOXIN; BACTERIOCIN; COLICIN E3; COMBRETASTATIN; CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL; METRONIDAZOLE; NITROREDUCTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIBODY DIRECTED ENZYME PRODRUG THERAPY; BACTERIAL GENE; BYSTANDER EFFECT; CLOSTRIDIUM; CLOSTRIDIUM BUTYRICUM; DNA MODIFICATION; DRUG DELIVERY SYSTEM; DRUG SAFETY; EXPRESSION VECTOR; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER; GRAM POSITIVE BACTERIUM; HYPOXIA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN TARGETING; SHORT SURVEY; STRAIN DIFFERENCE; SUICIDE GENE; TUMOR CELL; TUMOR VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BACTERIAL PROTEINS; CELL HYPOXIA; CLOSTRIDIUM; DRUG DELIVERY SYSTEMS; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; NEOPLASMS; RECOMBINANT PROTEINS; SPORES, BACTERIAL;

EID: 0036185916     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200202000-00002     Document Type: Short Survey

References (52)

1. Hypoxia in tumors: Its relevance, identification and modification
2. The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy
3. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells
4. Hypoxic stress proteins: Survival of the fittest
5. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
6. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma
7. Targeting gene expression to hypoxic tumor cells
8. Localization of the vegetative form of Clostridium tetani in mouse tumours following intravenous spore administration
9. Onkolyseversuche mit apathogen, anaerogen sporenbildern am Erhlich-tumor der maus
10. Zur beeinflussbarkeit verschiedener tiertumoren durch einen apathogenen clostridienstamm
11. Oncolysis by clostridia. I. Activity of Clostridium butyricum (M-55) and other nonpathogenic clostridia against the Ehrlich carcinoma
12. Versuche zur verbesserung der onkolyse mit dem clostridienstamm
13. Treatment of malignant brain tumours by Clostridium butyricum M55
14. The liquefaction (oncolysis) of malignant gliomas by a non pathogenic. Clostridium
15. Oncolysis of malignant glioma of the brain
16. Clostridial cloning vectors
17. Genetics of clostridia
18. Colonisation of the Clostridium in the body is restricted to hypoxic and necrotic areas of tumours
19. Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment
20. The role of angiogenesis in tumor growth
21. Combretastatins novel vascular targeting drugs for improving anti-cancer therapy. Combretastatins and conventional therapy
22. Specific targeting of cytosine deaminase to solid tumors by engineered Clostridium acetobutylicum
23. Improvement of Clostridium tumour targeting vectors evaluated in rat rhabdomyosarcomas
24. Recombinant plasmid DNA variation of Clostridium oncolyticum - Model experiments of cancerostatic gene transfer
25. A new cytotoxic DNA interstrand crosslinking agent, 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in Walker carcinoma cells
26. The nitroreductase in Walker cells that activates 5-(aziridin-1-y1)-4-hydroxylamino-2-nitro-benzamide is a form of NAD(P)H dehydrogenase (quinone) (EC 1.6.99.2)
27. The immune response elicited by mammary adenocarcinoma cells transduced with interferon-gamma and cytosine deaminase genes cures lung metastases by parental cells
28. Transduction of cytosine deaminase gene makes rat glioma cells highly sensitive to 5-fluorocytosine
29. In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus
30. Enzyme/prodrug gene therapy: Comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in human colorectal carcinoma cell line
31. Prodrug activation enzymes in cancer gene therapy
32. The heterodimeric protease clostripain from Clostridium histolyticum is encoded by a single gene
33. The potential therapeutic gain of radiation-associated gene therapy with the suicide gene cytosine deaminase
34. Genetic radiotherapy overcomes tumor resistance to cytotoxic agents
35. Gene therapy targeted by radiation preferentially radiosensitizes tumor cells
36. Structure of an endo-β-1,4-glucanase gene from Clostridium acetobutylicum P262 showing homology with endoglucanase genes from Bacillus spp.
37. Stable inheritance of shuttle vectors based on plasmid p1M13 in a mutant strain of Clostridium acetobutylicum
38. Expression of cloned homologous fermentative genes in Clostridium acetobutylicum ATCC 824
39. Stable Escherichia coli-Clostridium acetobutylicum shuttle vector for secretion of murine tumor necrosis factor alpha
40. Ionizing radiation activates transcription of the EGR1 gene via CarG elements
41. Spatial and temporal control of gene therapy using ionizing irradiation
42. Development of synthetic promoters for radiation-mediated gene therapy
43. General microbiology of recA: Environmental and evolutionary significance
44. Increasing specificity of anti-tumor therapy: Cytotoxic protein delivery by non-pathogenic clostridia under regulation of radio-induced promoters
45. The use of radio-induced bacterial promoters in anaerobic conditions: A means to control gene expression in Clostridium mediated therapy for cancer
46. Radioresponsive recA promoter significantly increases TNFα production in recombinant clostridia after 2 Gy irradiation
47. Insertion or deletion of the Cheo box modifies radio-inducibility of Clostridium promoters
48. Tumor-targeted Salmonella as a novel anticancer vector
49. Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo
50. Bifidobacterium longum as a delivery system for cancer gene therapy: Selective localization and growth in hypoxic tumors